Ticker: KALV

Company: Carbylan Therapeutics, Inc.

Person: Christopher Yea, officer

Transaction date: Nov. 21, 2025

Reporting date: Nov. 26, 2025

Average share price: -22.899481525157235

Sold 2544.0 shares for 58256.28